AccessPak for HIV PEP Expanded with Viracept and Claforan in D5W
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Claforan in D5W and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: cefotaxime
Brand name: Claforan, Claforan ADD-Vantage
Synonyms: Claforan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Claravis
- AccessPak for HIV PEP Expanded with Viracept-Clarifoam EF
- AccessPak for HIV PEP Expanded with Viracept-Clarinex
- AccessPak for HIV PEP Expanded with Viracept-Clarinex (Desloratadine Syrup)
- AccessPak for HIV PEP Expanded with Viracept-Clarinex (Desloratadine Tablets)
- AccessPak for HIV PEP Expanded with Viracept-Clarinex Reditabs
- Claforan in D5W-Accolate
- Claforan in D5W-Accretropin
- Claforan in D5W-Accucaine
- Claforan in D5W-AccuHist Drops
- Claforan in D5W-AccuHist PDX Drops
- Claforan in D5W-AccuHist PDX Syrup